View Item 

Show simple item record

Impact of pulmonary hypertension on transplant outcomes in pediatric cardiomyopathy patients
dc.contributor.authorBuddhe, Sujathaen_US
dc.contributor.authorDu, Weien_US
dc.contributor.authorL’ecuyer, Thomasen_US
dc.date.accessioned2012-07-12T17:25:13Z
dc.date.available2013-08-01T14:04:40Zen_US
dc.date.issued2012-06en_US
dc.identifier.citationBuddhe, Sujatha; Du, Wei; L’ecuyer, Thomas (2012). "Impact of pulmonary hypertension on transplant outcomes in pediatric cardiomyopathy patients." Pediatric Transplantation 16(4). <http://hdl.handle.net/2027.42/92094>en_US
dc.identifier.issn1397-3142en_US
dc.identifier.issn1399-3046en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/92094
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherOutcomesen_US
dc.subject.otherCardiomyopathyen_US
dc.subject.otherPulmonary Hypertensionen_US
dc.subject.otherHeart Transplantationen_US
dc.subject.otherPediatricsen_US
dc.titleImpact of pulmonary hypertension on transplant outcomes in pediatric cardiomyopathy patientsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherSection of Pediatric Cardiology, Carmen and Ann Adams Department of Pediatrics, The Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USAen_US
dc.identifier.pmid22471690en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/92094/1/j.1399-3046.2012.01678.x.pdf
dc.identifier.doi10.1111/j.1399-3046.2012.01678.xen_US
dc.identifier.sourcePediatric Transplantationen_US
dc.identifier.citedreferenceDaftari B, Alejos JC, Perens G. Initial experience with sildenafil, bosentan, and nitric oxide for pediatric cardiomyopathy patients with elevated pulmonary vascular resistance before and after orthotopic heart transplantation. J Transplant 2010: 2010: 656984.en_US
dc.identifier.citedreferenceFenton MJ, Chubb H, McMahon AM, Rees P, Elliott MJ, Burch M. Heart and heart‐lung transplantation for idiopathic restrictive cardiomyopathy in children. Heart 2006: 92: 85 – 89.en_US
dc.identifier.citedreferenceRusso LM, Webber SA. Idiopathic restrictive cardiomyopathy in children. Heart 2005: 91: 1199 – 1202.en_US
dc.identifier.citedreferenceKirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White‐Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988: 7: 331 – 336.en_US
dc.identifier.citedreferenceCostard‐Jackle A, Hill I, Schroeder JS, Fowler MB. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991: 84 ( 5 Suppl ): III329 – III337.en_US
dc.identifier.citedreferenceMcCarthy JF, McCarthy PM, Massad MG, et al. Risk factors for death after heart transplantation: Does a single‐center experience correlate with multicenter registries? Ann Thorac Surg 1998: 65: 1574 – 1578; discussion 8–9.en_US
dc.identifier.citedreferenceGorlitzer M, Ankersmit J, Fiegl N, et al. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation? Transpl Int 2005: 18: 390 – 395.en_US
dc.identifier.citedreferenceMurali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experience. Am Heart J 1993: 126: 896 – 904.en_US
dc.identifier.citedreferenceFrigerio M, Gronda E, Danzi GB, et al. [Short‐term survival after heart transplantation: The relationships between preoperative hemodynamics, organ function and postoperative clinical events]. G Ital Cardiol 1995: 25: 1 – 9.en_US
dc.identifier.citedreferenceZeng Z, Jiang Z, Wang CS, Luo H, Huang YF, Jin XH. Preoperative evaluation improves the outcome in heart transplant recipients with pulmonary hypertension – retrospective analysis of 106 cases. Transplant Proc 2010: 42: 3708 – 3710.en_US
dc.identifier.citedreferenceJohn R, Rajasinghe H, Chen JM, et al. Impact of current management practices on early and late death in more than 500 consecutive cardiac transplant recipients. Ann Surg 2000: 232: 302 – 311.en_US
dc.identifier.citedreferenceGoland S, Czer LS, Kass RM, et al. Pre‐existing pulmonary hypertension in patients with end‐stage heart failure: Impact on clinical outcome and hemodynamic follow‐up after orthotopic heart transplantation. J Heart Lung Transplant 2007: 26: 312 – 318.en_US
dc.identifier.citedreferenceKlotz S, Wenzelburger F, Stypmann J, et al. Reversible pulmonary hypertension in heart transplant candidates: To transplant or not to transplant. Ann Thorac Surg 2006: 82: 1770 – 1773.en_US
dc.identifier.citedreferenceDrakos SG, Kfoury AG, Gilbert EM, et al. Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant 2007: 26: 319 – 323.en_US
dc.identifier.citedreferenceIberer F, Wasler A, Tscheliessnigg K, et al. Prostaglandin E1‐induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation. J Heart Lung Transplant 1993: 12: 173 – 178.en_US
dc.identifier.citedreferenceLiden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Eur J Cardiothorac Surg 2009: 35: 1029 – 1034; discussion 34–5.en_US
dc.identifier.citedreferenceGajarski RJ, Towbin JA, Bricker JT, et al. Intermediate follow‐up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol 1994: 23: 1682 – 1687.en_US
dc.identifier.citedreferenceWebber SA, Fricker FJ, Michaels M, et al. Orthotopic heart transplantation in children with congenital heart disease. Ann Thorac Surg 1994: 58: 1664 – 1669.en_US
dc.identifier.citedreferenceButler J, Stankewicz MA, Wu J, et al. Pre‐transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant 2005: 24: 170 – 177.en_US
dc.identifier.citedreferenceChen JM, Levin HR, Michler RE, Prusmack CJ, Rose EA, Aaronson KD. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg 1997: 114: 627 – 634.en_US
dc.identifier.citedreferenceKawaguchi A, Gandjbakhch I, Pavie A, et al. Cardiac transplant recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options. Circulation 1989: 80 ( 5 Pt 2 ): III90 – III96.en_US
dc.identifier.citedreferenceTamisier D, Vouhe P, Le Bidois J, Mauriat P, Khoury W, Leca F. Donor‐recipient size matching in pediatric heart transplantation: A word of caution about small grafts. J Heart Lung Transplant 1996: 15: 190 – 195.en_US
dc.identifier.citedreferenceBourge RC, Naftel DC, Costanzo‐Nordin MR, et al. Pretransplantation risk factors for death after heart transplantation: A multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 1993: 12: 549 – 562.en_US
dc.identifier.citedreferenceErickson KW, Costanzo‐Nordin MR, O’Sullivan EJ, et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 1990: 9: 526 – 537.en_US
dc.identifier.citedreferenceFukushima N, Gundry SR, Razzouk AJ, Bailey LL. Risk factors for graft failure associated with pulmonary hypertension after pediatric heart transplantation. J Thorac Cardiovasc Surg 1994: 107: 985 – 989.en_US
dc.identifier.citedreferenceShaddy RE. Pulmonary hypertension in pediatric heart transplantation. Prog Pediatr Cardiol 2000: 11: 131 – 136.en_US
dc.identifier.citedreferenceShaddy RE, Naftel DC, Kirklin JK, et al. Outcome of cardiac transplantation in children. Survival in a contemporary multi‐institutional experience. Pediatric Heart Transplant Study. Circulation 1996: 94 ( 9 Suppl ): II69 – II73.en_US
dc.identifier.citedreferenceTenderich G, Koerner MM, Stuettgen B, et al. Pre‐existing elevated pulmonary vascular resistance: Long‐term hemodynamic follow‐up and outcome of recipients after orthotopic heart transplantation. J Cardiovasc Surg (Torino) 2000: 41: 215 – 219.en_US
dc.identifier.citedreferenceOfori‐Amanfo G, Hsu D, Lamour JM, et al. Heart transplantation in children with markedly elevated pulmonary vascular resistance. J Heart Lung Transplant 2006: 25: S49 – S50.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1399-3046.2012.01678.x.pdf
Size:
98.88KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.